News

Robex Resources Inc.: June 2025 Quarterly Activities Report
West African gold producer and developer Robex Resources Inc ("Robex" or the "Company") (TSX-V: RBX | ASX: RXR | OTC: RSRBF | ...
Llama Group SA: Llama Group Publishes Its H1 20251 Revenue
Llama Group SA (ISIN code: BE0974334667 Ticker: ALLAM) announces that its consolidated normalized2 revenue for the first half of 2025 amounts to 1.131 K, representing a slight 8% ...
Ambiq Announces Launch of Initial Public Offering
Ambiq Announces Launch of Initial Public Offering AUSTIN, Texas, July 21, 2025 (GLOBE NEWSWIRE) -- Ambiq Micro, Inc. ("Ambiq" ...
Sequana Medical NV: Use of alfapump to control ascites enabling elective umbilical hernia repair published in Hernia
Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without trea ...
SCOR announces the availability of its 2025 Interim Financial Report
Press releaseJuly 31, 2025 - N° 12 SCOR announces the availability of its 2025 Interim Financial Report SCOR ("SCOR" or the "Company") announces the availability and the filing with the French ...
1329308 B.C. LTD. Enters into Letter of Intent with Relief AI Inc.
B.C. Ltd. (the "Company") is pleased to announce that is has entered into an arm's length binding letter of intent (the "LOI") with ...
Pila Pharma AB: PILA PHARMA announces updated dates for last day of trading with paid subscribed units and first day of trading in new shares
PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") announces that the last day of trading in paid subscribed units (Sw. BTU) in connection with the Company's rights issue of units which the Board ...
BriaCell Therapeutics Corp.: BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology ...
MaxCyte, Inc: MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline
MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development ...
Eco Oro Minerals Corp.: Eco Oro Seeks Annulment of ICSID Tribunal Decision on Damages and Announces US$4.5 Million Financing
Eco Oro Minerals Corp. (CSE: EOM) ("Eco Oro" or the "Company") announces it has filed an application to annul the damages award issued on ...
Ball Corporation: Board Declares Quarterly Dividend and Elects New Officer
Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per ...
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company dedicated to building a portfolio of innovative ...